Company profile
OrthoPediatrics Corp.
NASDAQ: KIDS · Healthcare · Medical - Devices
#278 of 1,418 Healthcare companies by revenue61st-percentile growth
EA Score
69BFH 66DQ 79GM 57SS 67
v0.1 · 65/100 weight · provisional
↑ filing timeliness, workforce scale · ↓ growth stability, listing tenure
Methodology →Revenue TTM
$243.3M
Rev growth YoY (TTM)
+14.5%
Net income (FY)
-$39.6M
Employees
602
as of 2026-08-11
Market cap
$597.9M
as of 2026-08-11
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$236.3M$236.3M2025
Net income-$39.6M-$39.6M2025
Operating income-$39.2M-$39.2M2025
Total assets$508.6M$508.6M2025
Liabilities$162.0M$162.0M2025
Equity$346.6M$346.6M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Trauma and Deformity70%
Spine28%
Sports Medicine And Other2%
By geography
UNITED STATES79%
Non-US21%
The read
What is OrthoPediatrics Corp.’s revenue?
OrthoPediatrics Corp. booked $236.3M in FY2025 revenue, growing 15% year over year — faster than most Healthcare companies we track, at a -16.8% net margin.
Peers · Healthcare
Definitive Healthcare Corp.53DSTAAR Surgical Company67BVaxart, Inc.72BAkebia Therapeutics, Inc.66BAnaptysBio, Inc.75B+Cerus Corporation74BKey facts
CEODavid R. Bailey
SectorHealthcare
IndustryMedical - Devices
HeadquartersWarsaw, IN
ExchangeNASDAQ: KIDS
Employees602
IPO date2017-10-13
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.